In this article, we describe our methods and protocols using collision-induced dissociative 2 chemical crosslinking-tandem mass spectrometry (CID-CXL-MS/MS) analysis and the practical 3 considerations when implementing these reagents and methodology for protein crosslinking 4 studies. The synthesis of our novel chemical crosslinkers is described as well as their use for 5 effectively labeling protein and protein complexes. Several sample preparation methods for 6 liquid chromatography-tandem mass spectrometry are provided including the enrichment of 7 interpeptide crosslinks. For identification of CID-CXL-MS/MS crosslinks, details regarding MS 8 acquisition parameters and the utilization of various mass spectrometers are addressed along with 9 post-data acquisition analysis to identify interpeptide crosslinks. Once the CID-CXL-MS/MS 10 approach is optimized for a protein target or a set of targets, it can be used as a tool for biological 11 research for studying protein structure when integrated with data obtained using other 12 techniques, such as NMR and X-ray crystallography, or extended to the study of protein-protein 13 interactions in physiological environments. 14 15
Introduction 20
Chemical crosslinking (CXL) combined with mass spectrometry (MS) is a viable 21 approach to study the low-resolution structure of proteins and protein complexes that provides 22 insight regarding protein interactions and topology [1] [2] [3] . These measurements require relatively 23
The SuDP, SuDPG, and SuVP reagents are synthesized and purified as described 1 previously [22, 23, 27] . Synthesis of SuDP is performed by first coupling the Fmoc-Asp(OtBu)-2 OH to the Fmoc-Pro-NovaSyn TGT extremely acid-sensitive preloaded resin in a batch wise 3 manner using the active ester method. Following deprotection of the resin-bound amino acid, 4 active esters are formed using Fmoc-amino acid, N-hydroxybenzotriazole, and 5 diisopropylcarbodiimide in a 5:5:5.5 molar ratio to the resin-bound amino acid. Following Fmoc 6 deprotection of Fmoc-Asp(OtBu)-OH, succinic anhydride is added to introduce a carboxylate 7 group to the N-terminus of the reagent linker region. The completed linker region is cleaved 8 from the resin with 1% TFA in dichloromethane. Following reversed-phase high-performance 9 liquid chromatography (HPLC) purification, esterification of the dicarboxylic acid is performed 10 using either di(N-succinimidyl) oxalate or di(N-succinimidyl) carbonate. The esterified product 11 is purified via HPLC, dried under vacuum, and stored at -20 °C. Before use, the aspartyl side 12 chain tert-butyl protecting group is removed by the addition of 90% TFA/5% water/5% DMSO 13 (v/v/v), and the mixture is stirred at ambient temperature for 10 min, then dried under vacuum. 14 The SuDP crosslinker is purified via HPLC to remove deprotection contaminants, dried under 15 vacuum, and then is stored at -80°C. 16 Synthesis of SuVP is performed in the same manner as the SuDP reagent using Val-OH in place of Fmoc-Asp(OtBu)-OH; however the final purification of the SuVP reagent is 18 performed via HPLC immediately following esterification. Synthesis of SuDPG is performed in 19 a similar fashion as SuDP except using Fmoc-Gly-NovaSyn TGT extremely acid sensitive 20 preloaded resin and Fmoc-Pro-OH to introduce the additional glycyl moiety. 21
Quantification of the SuDPG, SuDP, and SuVP reagents is performed by measuring the 22 absorbance obtained at 260 nm of a small aliquot from the HPLC-purified product and 23 calculating its concentration based on a standard curve generated from various concentrations of 1 disuccinimidyl suberate (DSS) and saponification of the NHS-esters using NaOH [30] . The 2 structures of all three reagents and their extended crosslinker lengths used for calculating 3 maximum distance constraints are presented in Figure 2 . 4 5
Methods 6
The methods described below pertain to those previously developed to study protein 7 structure [4, 22, 23, 27, 29] and those currently being utilized in our laboratory. The general 8 workflow of the CID-CXL-MS/MS approach ( Figure 3 ) consists of consecutive steps of protein 9 crosslinking, possible purification of the crosslinked proteins, enzymatic digestion, separation 10 and enrichment of the crosslinked peptides, followed by reversed-phase liquid chromatography-11 tandem mass spectrometry analysis using LC/MS 2 and LC/MS 3 acquisition methods. The 12 protocols for these steps are described as well as alternatives pertaining to the CID-CXL-MS/MS 13 approach. It should be noted that before attempting an analysis of a protein or protein system of 14 interest, the protocols chosen for a particular CID-CXL-MS/MS experiment should be evaluated 15 using bovine serum albumin (BSA) as a control. 16 17
Protein crosslinking with CID-CXL-MS/MS crosslinkers 18
A typical protein crosslinking experiment with our CID-CXL-MS/MS reagents [4, 22, 23, 19 27, 29] usually contains 10 µM of protein in 100 mM sodium phosphate, 25 mM NaCl, 1.0 mM 20 EDTA, pH 7.5. Aliquots of our CID-CXL-MS/MS reagent are dissolved in DMSO and added to 21 the protein solutions to produce a protein-to-crosslinker molar ratio (defined as the ratio of the 22 number of moles of protein to the number of moles of crosslinker) of 1:0 (control), 1:50, 1:100, 23 1:200, and 1:300 while keeping the final organic concentration below 1-3% of the total reaction 1 volume. The crosslinking reaction is performed at ambient temperature for 30 to 60 min 2 followed by quenching with 1.0 M Tris or 1.0 M glycine, pH 7.5, to produce a final 3 concentration of 10-50 mM, and then the quenching reaction is incubated for 15-30 min at 4 ambient temperature. Samples are then analyzed by SDS-PAGE using a 4-20% Bis-Tris gel 5 (Invitrogen Life Technologies, www.lifetechnologies.com), and proteins are visualized with 6
Coomassie staining. Based on this analysis, appropriate protein-to-crosslinker molar ratios 7 (typically 1:100 or 1:200 for proteins of the size of BSA, but these ratios will vary depending on 8 the size and number of reactive amino acid residues of the proteins being analyzed) will be 9 selected for either in-gel, in-solution or filter-assisted proteolytic digestion. 10 11
Sample preparation of proteins crosslinked with CID-CXL-MS/MS crosslinkers 12
Depending on the nature of the protein sample after crosslinking, samples can be 13 prepared using in-gel, in-solution, or filter-aided protease digestion as described below. 14 Although these methods use trypsin digestion, other specific and nonspecific proteases can be 15 used to provide an alternative for identify additional crosslinked products [22, 31] . 16 17
In-gel sample preparation 18
To assess the extent of crosslinking and to separate crosslinked complexes from 19 uncrosslinked components, SDS-PAGE is very effective [4, 22, 23] . After quenching the CID-20 CXL-MS/MS crosslinking reaction with glycine or Tris-HCl, the solvent is removed via vacuum 21 centrifugation to near dryness (about 10 µl remaining), which is then diluted with SDS PAGE 22 running buffer. Depending on the complexity of the protein system and the volume of the CID-23 CXL-MS/MS crosslinking reaction, the sample is diluted with the appropriate amount of loading 1 buffer and an aliquot sufficient to visualize the proteins by Coomassie staining is then loaded for 2 each lane of a 15% SDS PAGE gel. After electrophoresis, protein bands are visualized by 3
Coomassie staining. 4
To identify crosslinked peptide products for the separated protein complexes, in-gel 5 digestion can be performed using a modified protocol previously described [32] . Protein bands 6 of interest are excised using a razor blade or X-Acto knife and are destained using 1 ml of 40% 7 acetonitrile/60% 50 mM ammonium bicarbonate, pH 8.0. After 1 h of destaining with gentle 8 mixing using a rocker, each gel slice is reduced for 1 h at 37°C with 5 mM DTT in 50 mM 9 ammonium bicarbonate, pH 8.0, and then cysteinyl residues are alkylated with 20 mM 10 iodoacetamide in 50 mM ammonium bicarbonate, pH 8.0, at ambient temperature in the dark for 11 1 h. In-gel digestion is performed overnight at 37°C using trypsin resuspended in 50 mM 12 ammonium bicarbonate, pH 8.0, at a final 1:5 (w/w) enzyme-to-protein ratio. Peptides are 13 extracted from the gel pieces three times with 200 μl of 60% acetonitrile/35% 50 mM 14 ammonium bicarbonate, pH 8.0/5% formic acid (v/v/v) with sonication in a water bath for 20 15 min. Extractions are pooled, dried under vacuum centrifugation, and stored at -80°C. 16 17
In-solution sample preparation 18
After quenching the CID-CXL-MS/MS crosslinking reaction with glycine or Tris-HCl, 19 the sample can be subjected to in-solution proteolytic digestion as previously described [4, 22, 20 23, 27, 29] . A typical protocol is described here, but it can be modified as needed, depending on 21 the extent of chemical denaturation, disulfide bond reduction and cysteinyl alkylation that is 22 required for the protein/protein complex being studied. The samples are reduced with 40 mM 23 DTT for 1 h at 37°C and cysteinyl residues are alkylated in the dark for 1 h at ambient 1 temperature with 200 mM iodoacetamide. To remove excess reagents, the sample is dialyzed 2 overnight against 50 mM ammonium bicarbonate, pH 8.0, using a 3000 MWCO Slide-A-Lyzer 3 dialysis cassette (Pierce Biotechnology (www.piercenet.com). Dialyzed samples are digested in 4 solution overnight at 37°C with trypsin using an enzyme-to-protein ratio of 1:50 (w/w) then 5 dried via vacuum centrifugation and stored at -80ºC. To provide better protease digestion of 6 crosslinked proteins, the sample can first be denatured by adding solid guanidine-hydrochloride 7 (Gdn-HCl) to make a concentration of 9 M Gdn-HCl following by incubating the sample in a 8 boiling water bath for 5 min; then the reduction, alkylation, dialysis, and proteolytic digestion are 9 performed as described above. Alternatively, after reduction and alkylation, the sample can be 10 diluted to 1 M Gdn-HCl by adding 50 mM ammonium bicarbonate, pH 8.0, prior to tryptic 11 digestion; following digestion, the peptides can be purified by solid-phase extraction (SPE) using 12 a Grace Alltech Prevail C 18 Extract-Clean column (www.grace.com) connected to a vacuum 13 manifold, dried via vacuum centrifugation, and stored at -80°C. 14 15
Filter-aided sample preparation (FASP) 16
To facilitate a more efficient sample workup of multiple crosslinked samples, we have 17 been using filter-aided sample preparation (FASP) as previously described for proteomic 18 analysis [33] . After quenching the CID-CXL-MS/MS crosslinking reaction with glycine or HCl, the sample is reduced with 100 mM dithiothreitol to reach a final concentration of 5 mM 20 and incubated at 56°C for 30 min. After incubation, the crosslinked sample is mixed with 200 μl 21 of 8 M urea and transferred to a Vivacon 500 10kDa MWCO filter column (a smaller or larger 22 MWCO filter can be used, depending the nature of the protein sample). The filtering device is 23 centrifuged at ambient temperature for 30 min at 14,000xg. Then the retained protein on the filter 1 is washed with 200 μl of 8 M urea and the flow-through is discarded. For alkylation, 100 μl of 50 2 mM iodoacetamide is added, and the whole filter unit is placed in the dark for 20 min at ambient 3 temperature followed by centrifugation at 14,000xg for 20 min. The concentrate is diluted with 4 100 μl of 8 M urea and centrifuged for another 20 min and this step is repeated two additional 5 times. Afterwards, 100 μl of 50 mM ammonium bicarbonate, pH 8.0, is added and centrifuged 6 for another 20 min and this step is repeated two additional times. The collection tube used for the 7 washes is replaced with a new tube, then 10 μl of trypsin solution (1.0 μg/μl in resuspension 8 buffer provided by the manufacturer) and 40 μl of 50 mM ammonium bicarbonate, pH 8.0, are 9 mixed gently and placed on the filter, then the filter-and-tube assembly is placed in a float and 10 incubated for 4-18 h in a water bath at 37 ºC. The digested protein sample is then removed from 11 the filter with 80 μl of 50 mM ammonium bicarbonate, pH 8.0. After centrifugation, the solvent 12 is evaporated (or reduced in volume) via vacuum centrifugation and stored at -80ºC. 13 14
Strong cation exchange enrichment of interpeptide crosslinks 15
Although CID-CXL-MS/MS crosslinked samples that have been proteolytically digested 16 can be analyzed directly by LC/MS/MS, the sample complexity introduced by crosslinking and 17 the low stoichiometry of interpeptide crosslinked products may require the implementation of 18 strong cation ion exchange (SCX) to separate low charged peptides from higher charged species, 19 thus enriching for interpeptide crosslinked products [12] . Peptides from proteolytic digests (these 20 samples may have to be purified by SPE if they contain any competing cations such as Tris or 21 guanidium) are separated by SCX using a pipette tip in-house packed with Poros XS material 22 (www.appliedbiosystems.com). The peptide mixture is loaded onto the SCX column, and then 23 bound peptides are step-wise eluted with 100 mM, 200 mM, 300 mM and 1 M NaCl containing 1 0.1% TFA. Peptides from each fraction were desalted using a separate SPE pipette tip in-house 2 packed with Poros OLIGO R3 material (www.appliedbiosystems.com), dried via vacuum 3 centrifugation, and stored at -80°C. 4 4 is used for MS 2 activation, but can be increased to 2x10 4 in an effort to generate product 2 ions of higher intensity. Dynamic exclusion settings will depend upon the sample complexity 3 and the resolution of the separation achieved during the LC gradient. For some of our 4 acquisitions, we have used a dynamic exclusion repeat count of 2, a dynamic exclusion repeat 5 duration of 60 s, and an exclusion duration of 90 s. The maximum allowed ion accumulation 6 times of 200 ms for the MS scans and 500 ms for the MS 2 scans are employed with the resolving 7 power set to 60,000 for the MS scans and 15,000 for the MS 2 scans at m/z 400. 8 9 3.5.2 Data-dependent acquisition using LC/MS 3 
10
Ion trap CID using data-dependent multiactivation (LC/MS 3 ) was performed as 11 previously described [23, 27] . A series of continuously repeating scan events is employed to 12 promote CID-CXL-MS/MS crosslink product detection. A survey MS scan is performed from 13 m/z 400 to 2000 for the first scan event. The second scan event (the CID dissociation scan for 14 the precursor crosslinked species to promote crosslinker cleavage), the most abundant ion from 15 the survey MS scan is data-dependently selected and subjected to CID for MS 2 analysis. For the 16 next series of scan events (at least two, but more may be used for systems capable of 17 microsecond scanning), the most abundant ions from the second scan are then data-dependently 18 selected and individually subjected to CID for MS 3 analysis. All CID events can be performed 19 using the typical settings employed for linear peptide analysis (e.g., a normalized collision 20 energy setting of 35% on Thermo Scientific ion traps), however a lower value of 25% (which 21 represents around a 30% reduction for this instrument setting) implemented on scan event two 22 (i.e., the crosslinker dissociation event) can be used to minimize b-and y-ion formation to 23 promote the detection of the modified linear peptides generated from the CID-CXL-MS/MS 1 interpeptide crosslink during the subsequent MS 3 generators are publically available on the web). For interpeptide crosslinker analysis, high mass 19 measurement accuracy of the precursor and product ions is required (typically between 10-15 20 ppm) as well as the known mass of the modifications remaining on the labeled residues due to 21 the nature of the cleavable crosslinker (which are listed below for SuDP in Section 3.6.2). Due 22 to the asymmetric nature of the our CID-CXL-MS/MS crosslinkers, each dataset needs to be 23 searched twice in order to account for the combination of crosslinker modifications on both 1 peptides of interpeptide crosslinked species since a given reactive residue side chain of a protein 2 can react with either end of our CID-CXL-MS/MS reagents. It should also be noted that these 3 asymmetric interpeptide crosslink pairs may be chromatographically resolved or essentially 4 coelute; although we have not conducted a formalized systematic study, the degree of separation 5 or coelution is dependent upon the type of stationary phase used in the reversed-phase separation 6 and the amino acid residue sequence and length of the peptides involved in the crosslink. 7 8 3.6.2 Analysis of crosslinked products using data obtained from LC/MS 3 acquisitions 9
All product ion spectra resulting from LC/MS 3 acquisitions can be searched using any 10 database or de novo searching algorithm that is used to identify modified linear peptides as 11 following product ion spectrum (the second MS scan event) is also examined for the presence of 14 the two individual SuD-and P-modified peptide product ions generated from dissociation at the 15 aspartyl-prolyl bond within the crosslinking reagent in order to verify that the modified peptides 16 identified from the MS 3 product ion spectra were unequivocally originated from the CID-CXL-17 MS/MS interpeptide crosslink. This comparison can be achieved by manual verification or 18 implementing in-house developed scripts as previously described [29] . It should be noted that 19 the nature of the acquired data is readily amenable to custom-based scripts that can be written to 20 facilitate the process of automating CID-CXL-MS/MS data analysis in any lab specific data 21 management system and accompanying workflows. 22
Results and Discussion 1
For structural analysis of proteins and protein-protein interactions, the conditions 2 required for promoting effective crosslinking needs to be established. The methods and 3 protocols for our CID-CXL-MS/MS approach can be used as described in Section 3, but some 4 aspects are worthy of discussion in order to address the analytical aspects of the crosslinking 5 reaction and some additional alternatives for identification of interpeptide crosslinks. 6 7
Establishing and assessing effective protein crosslinking reaction conditions 8
The CID-CXL-MS/MS reagents are homobifunctional crosslinkers containing amine 9 reactive N-hydroxysuccinimide (NHS) esters (Figure 2 ), thus effective crosslinking conditions 10 for a given protein or protein complex and appropriate pH conditions to promote protein 11 solubility and crosslinker reactivity need to be established. For reagents like SuDP, as well as 12 any other crosslinkers that utilize NHS-esters, the optimal amine reactivity is going to be around 13 pH 7.5 (i.e., between pH 7-8). When the pH is lower than 7, the kinetics of the crosslinking 14 reaction is reduced, and above pH 8, hydrolysis of the NHS ester becomes an issue. For proteins 15 having acidic or basic pIs, this is not an issue, but if the protein has a pI close to 7, then a pH at 6 16 or 8 is needed and will compromise labeling using crosslinking reagents with NHS or sulfo-NHS 17 esters. Another factor to consider is buffer compatibility. Phosphate buffer is preferred to due to 18 its ability to buffer at neutral pH and being unreactive to NHS-based crosslinkers. If a protein 19 prefers amine-based buffers, those containing tertiary amines such as MOPS or HEPES are 20 acceptable, unlike Tris which contains a primary amine and thus is often use to quench the 21 crosslinking reaction. 22
In developing the use of our CID-CXL-MS/MS reagents, assessment of various reaction 1 conditions can be performed with a variety of biochemical methods. One that is easily 2 implemented uses SDS PAGE analysis to monitor the formation of crosslinked proteins and 3 protein complexes as a function of increasing crosslinker concentrations. This type of analysis 4 provides a visual confirmation whether suitable crosslinking or over-crosslinking is occurring 5 based on the increased detection of higher order oligomers and the decrease in the presence of 6 lower molecule weight monomers. If the stoichiometric oligomerization state of a protein is 7 unknown, it must be determined or verified by other biochemical measurements since 8 identification of crosslinked peptides originating from over-crosslinked samples may not reflect 9 native structural features or interactions. After crosslinking, confirmation of secondary structural 10 integrity can be assessed via circular dichroism as we have performed previously[27], whereas 11 potential changes in tertiary structure can be probed by conducting functional or enzymatic 12 assays. Typically a protein-to-crosslinker ratio of 1:100 is used with an incubation time of 30 13 min at ambient temperature and suitable for providing sufficient crosslinking without altering 14 protein structure of the average cytosolic protein, but some other method of verification to assess 15 protein conformation dynamics or regions of high flexibility may be required to explain 16 crosslinks that do not conform to a defined maximum distance constraint for a given structure or 17 structural model. 18
Since there may not be a suitable assay to measure secondary or tertiary structural 19 changes due to the protein complex being studied, we have started to implement the labeling of 20 the proteins with acetyl-NHS (Figure 3) , which has the same reactive moiety as our CID-CXL-21 MS/MS reagents, but its smaller size allows for all potential reactive Lys residues under the 22
given crosslinking conditions to be readily measured by LC/MS/MS analysis. These data can be 23 used to assess potential Lys residue amine reactivity with the NHS-based CID-CXL-MS/MS 1 reagents, and the application of different proteases during digestion can be used to generate a 2 peptide map to aid in the selection of a suitable proteases or proteases for the digestion of 3 crosslinked samples. In addition the use of noncleavable crosslinkers like DSS, which is very 4 similar in length to SuDP and SuVP and has the same reactive ester moieties, could be used to 5 test sample labeling and workup conditions prior to using the synthesized reagents. 6 7
Assessing SCX enrichment of interpeptide protein crosslinks 8
Although the detection of crosslinked products can be performed from digested proteins 9 labeled with our CID-CXL-MS/MS reagents without implementing SCX enrichment, 10 fractionation using offline SCX facilitates the enrichment of higher charged state peptides, thus 11 increasing the detection of interpeptide crosslinks. The SCX enrichment described in Section 3.2 12 utilizes a series of elutions containing increasing concentrations of NaCl (up to 1 M), but this 13 required each fraction to be desalted using SPE prior to LC/MS/MS analysis. We have currently 14 modified this method using ammonium formate since it is a volatile buffer and is easily removed 15 during solvent evaporation, thus obviating the need for SPE for each collected fraction. To 16 eliminate losses during sample handling, we have also used online SCX by modifying a nanoLC 17 system by adding an in-house packed SCX column coupled to a reversed-phase trap column 18 attached to a reversed-phase nanobore separation column; although this approach is relatively 19 effective, more work is required to provide reproducible separations. Regardless of the SCX 20 variation used, the efficiency of interpeptide crosslink detection is limited by missed cleavages in 21 unmodified peptides, which lead to higher charge state containing peptides that co-elute with 22 identification. Further characterization of product ions generated from CID-CXL-MS/MS 1 interpeptide crosslinks at the MS 2 CID (or HCD) stage using these instruments revealed the 2 presence of detectable and informative peptide backbone product ions. These ions were of 3 sufficient number and detectable abundance (based on the peptides comprising the interpeptide 4 crosslink) but did not preclude the formation of the released linear peptides that can be subjected 5 to MS 3 CID events as shown in the MS 2 product ion spectra reported in our previous work [4, 6 29] and illustrated in the data presented in Figure 5 . The BSA interpeptide crosslink shown in 7
Figure 5 was also identified in our previous study [29] in which a combination of an LC/MS 2 8 acquisition followed by a subsequent targeted LC/MS 3 analysis was shown to identify 28 unique 9 BSA interpeptide crosslinks using an unrestricted protein database. Based on the 10 crystallographic data used for structural interpretation, the interpeptide crosslink shown was 11 present on Lys residues within the maximum distance constraint of 23.9Å for the SuDP 12 crosslinker. As a result, instruments such as Q-TOFs and orbitrap Q-Exactives can also be used 13 to generate informative LC/MS 2 and LC/MS 3 data when performing protein crosslinking using 14 our CID-CXL-MS/MS reagents. 15
When using hybrid mass analyzers, the collected LC/MS 2 data can be analyzed by 16 database searching or de novo sequencing algorithms for the identification of CID-CXL-MS/MS 17 deadend and intrapeptide crosslinks (when acquiring product ion data for charge states ≥ +2) or 18 analyzed by searching algorithms designed for interpeptide crosslinks (when acquiring product 19 ion data for charge states ≥ +4). As indicated in Section 3.6.1, we have used MeroX [20], a 20 publically available search engine with a user-friendly interface, to identify CID-CXL-MS/MS 21 interpeptide crosslinks. Due to the asymmetric nature of our crosslinkers, each released linear 22 peptide can exist in two forms, such as the SuD-and P-modified species if the SuDP crosslinker 23 is used for labeling (Figure 5 ), thus two searches are required to identify both interpeptide 1 species. However, only one form of the interpeptide crosslink may be preferentially abundant 2 due to the chemical and topological nature of the protein being labeled. To take advantage of the 3 asymmetry of our crosslinkers, we are finalizing a searching algorithm (called CXLink) to better 4 identify interpeptide CID-CXL-MS/MS crosslinks using unrestricted databases with statistical 5 significance using data solely obtained from LC/MS 2 acquisitions. Nevertheless, we continue to 6 assess the various search engines for interpeptide crosslinks that become available and encourage 7 others to utilize this strategy when implementing our CID-CXL-MS/MS approach (or other 8 crosslinking approaches). According to our limited surveys we have concluded that for 9 confident structural analysis, manual inspection of identified interpeptide crosslinks is required 10 for verification in order to establish a threshold cutoff score for confident identification for a 11 given search algorithm. 
Conclusions 7
At this point in our research, we have laid the foundation for developing a comprehensive 8 and potentially high-throughput mass spectrometry method for studying protein structural 9 dynamics, interactions, and interaction networks using gas-phase cleavable crosslinkers. We 10 have presented here the methods and protocols needed to successfully use our CID-CXL-MS/MS 11 reagents in structural analysis of protein and protein interactions and have provided some 12 alternative considerations for determining appropriate crosslinking reaction conditions, 13 interpeptide crosslinking enrichment, and mass spectrometry data acquisitions and post-14 acquisition analyses to customize an approach for a given protein study and available LC-15 MS/MS analytical system. Although not discussed, our CID-CXL-MS/MS approach is also 16 amenable to combinatorial generation of a library of crosslinkers by inserting various amino 17 acids at the X position of the SuDX linker region, introduction of affinity tags for enrichment of 18 crosslinked products, the utilization of stable isotope coding of reagents to enable relative 19 quantitation and the analytical benefits that may be afforded by the use of ion mobility 20 measurements to enhanced detection crosslinked products in order to capture the heterogeneity 21 of protein structural interactions and dynamics. 22 
